MBB Public Markets I LLC Makes New Investment in Waters Corporation $WAT

Key Points

• MBB Public Markets I LLC acquired 898 shares of Waters Corporation, valued at approximately $331,000, during the first quarter.
• The company reported a Q2 EPS of $2.95, exceeding analysts' expectations, with revenue of $771.33 million, an 8.8% increase year-over-year.
• Analysts have varying ratings on Waters stock, with a consensus rating of "Hold" and a price target of $378.73.

MBB Public Markets I LLC acquired a new position in Waters Corporation (NYSE:WAT - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 898 shares of the medical instruments supplier's stock, valued at approximately $331,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. United Services Automobile Association acquired a new stake in Waters in the 1st quarter worth about $563,000. Goldman Sachs Group Inc. raised its position in shares of Waters by 3.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier's stock valued at $73,733,000 after buying an additional 6,976 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Waters by 3,228.6% in the 1st quarter. Jones Financial Companies Lllp now owns 3,262 shares of the medical instruments supplier's stock valued at $1,202,000 after buying an additional 3,164 shares in the last quarter. UniSuper Management Pty Ltd raised its position in shares of Waters by 0.9% in the 1st quarter. UniSuper Management Pty Ltd now owns 6,790 shares of the medical instruments supplier's stock valued at $2,503,000 after buying an additional 58 shares in the last quarter. Finally, Nissay Asset Management Corp Japan ADV raised its position in shares of Waters by 1.2% in the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 7,665 shares of the medical instruments supplier's stock valued at $2,825,000 after buying an additional 91 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Price Performance

WAT stock traded down $7.05 during trading on Friday, reaching $295.40. 326,673 shares of the company were exchanged, compared to its average volume of 570,240. The company has a 50-day moving average of $299.65 and a two-hundred day moving average of $333.38. The company has a market capitalization of $17.58 billion, a price-to-earnings ratio of 26.64, a P/E/G ratio of 2.82 and a beta of 1.07. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. During the same period in the prior year, the company earned $2.63 EPS. The firm's quarterly revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, equities analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

WAT has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Waters and gave the company a "hold" rating in a research report on Tuesday, August 5th. Scotiabank restated a "sector outperform" rating and issued a $465.00 target price on shares of Waters in a research report on Friday, July 11th. Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Wells Fargo & Company lowered their price objective on shares of Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 5th. Finally, UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, Waters has an average rating of "Hold" and an average target price of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.